Loading institutional data...
Loading institutional data...
Held by 281 of 2,417 reporting institutions (96th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 26% of free cash flow, leaving room to grow it and fund buybacks. Last year: $871.0M dividends + $0 buybacks = $871.0M returned on $3.41B FCF.
3 consecutive years of dividend increases · 4%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $12.61B 100.0% | $10.63B 100.0% |
| Total Operating Expenses | $13.44B | $10.37B | $10.50B | $17.48B | $13.47B | $9.87B | $10.74B | $12.62B | $10.90B 86.4% | $9.14B 86.0% |
| Operating Income | $2.37B | $2.09B | $2.24B | $1.75B | $1.50B | $1.55B | $1.43B | $1.59B | $1.71B 13.6% | $1.49B 14.0% |
| Interest Expense | $1.06B | $951.0M | $791.0M | $675.0M | $630.0M | $601.0M | $568.0M | $559.0M | $536.0M 4.3% | $472.0M 4.4% |
| Interest & Investment Income | $103.0M | $136.0M | $57.0M | $46.0M | $22.0M | $29.0M | $9.0M | $12.0M | $12.0M 0.1% | $20.0M 0.2% |
| Other Income (Expense), net | -$824.0M | -$721.0M | -$677.0M | -$636.0M | -$839.0M | -$473.0M | -$417.0M | -$378.0M | -$424.0M -3.4% | -$381.0M -3.6% |
| Pretax Income | $1.55B | $1.37B | $1.57B | $1.11B | $656.0M | $1.08B | $1.01B | $1.22B | $1.29B 10.2% | $1.10B 10.4% |
| Income Tax Expense | $88.0M | -$34.0M | $169.0M | $29.0M | -$130.0M | $37.0M | $71.0M | $98.0M | $175.0M 1.4% | $271.0M 2.5% |
| Net Income | $1.46B | $1.40B | $1.40B | $1.08B | $907.0M | $1.37B | $1.17B | $1.12B | $1.13B 9.0% | $868.0M 8.2% |
| Per Share | ||||||||||
| EPS (Basic) | $7.04 | $6.78 | $6.77 | $5.53 | $4.68 | $7.09 | $6.32 | $6.18 | $6.32 | $4.84 |
| EPS (Diluted) | $7.03 | $6.77 | $6.76 | $5.52 | $4.67 | $7.08 | $6.31 | $6.17 | $6.32 | $4.83 |
| Weighted Avg Shares (Basic) | 207.0M | 207.0M | 206.0M | 195.0M | 193.0M | 193.0M | 185.0M | 181.0M | 179.0M | 179.0M |
| Weighted Avg Shares (Diluted) | 207.0M | 207.0M | 206.0M | 196.0M | 194.0M | 193.0M | 185.0M | 181.0M | 179.0M | 179.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $208.0M is below the $1.35B due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~4.0% on $26.19B of debt.
Cash of $208.0M is below short-term debt of $882.0M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No current price collected.
Where each multiple sits in its own 14-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 12% against ROIC 4% — 8% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on DTE: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Cost of capital cannot be computed, so the spread is unknown.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | 14.0% | 8.2% |
| FY2017 | not reported | 13.6% | 9.0% |
Leverage and buybacks account for 8 points of the 12% return on equity in FY2025. The business earns 4% on the capital it employs; the rest is balance sheet.
ROE is on year-end equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: market_cap.
Converts 2.49x of reported profit into free cash flow over 5 years, with accruals negative.
Capex has been below depreciation for 7 consecutive years (0.00x on average over the last 5). Spending less than the asset base is consuming flatters free cash flow now and defers the cost — though depreciation also covers amortisation of acquired intangibles, which capex is not meant to replace.
Missing from our data, so excluded from this answer: share_based_compensation.
Stressed coverage of 1.6x sits between comfortable and thin.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 2.25x |
| 5% | 2.14x |
| 10% | 2.02x |
| 15% | 1.91x |
| 20% | 1.80x |
| 25% | 1.69x |
| 30% | 1.57x |
| 35% | 1.46x |
| 40% | 1.35x |
| 45% | 1.24x |
| 50% | 1.12x |
| 55% | 1.01x |
| 60% | 0.90x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Net debt is 6.2x EBITDA, so coverage today depends on earnings holding up rather than on the balance sheet.
No current price or share count, so the market's assumption cannot be solved for.
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. No TTM point: the four most recent quarters do not form a usable window.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: market_cap.
| Step | Amount | Running total |
|---|---|---|
| Net income | $1.46B | $1.46B |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | $1.95B | $3.41B |
| Operating cash flow | $3.41B | $3.41B |
| Capex | $0 | $3.41B |
| Free cash flow | $3.41B | $3.41B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | not reported | -6.1% | not reported |
| FY2021 | not reported | 9.9% | not reported |
| FY2022 | not reported | 20.2% | not reported |
| FY2023 | not reported | -19.9% | not reported |
| FY2024 | not reported | 3.5% | not reported |
| FY2025 | not reported | 20.2% | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -3.5 percent |
| FY2020 | -5.1 percent |
| FY2021 | -5.4 percent |
| FY2022 | -2.1 percent |
| FY2023 | -4.1 percent |
| FY2024 | -4.6 percent |
| FY2025 | -3.6 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 7 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Brandon David Director | Grant | 294 | $123.27 | — |
| 2026-10-01 | Torgow Gary Director | Grant | 294 | $123.27 | — |
| 2026-09-01 | Lauer Trevor F Vice Chairman & Group Pres. | Open-market sale | 5,000 | $135.71 | $679k |
| 2026-07-01 | Torgow Gary Director | Grant | 241 | $150.57 | — |
| 2026-07-01 | Brandon David Director | Grant | 241 | $150.57 | — |
| 2026-05-14 | Muschong Lisa A. VP, Corp Sec & Chief of Staff | Open-market sale | 1,000 | $143.72 | $144k |
| 2026-05-08 | 4 co-filers Group filing | Option exercise | 1,219 | $0.00 | $0 |
| 2026-05-08 | 4 co-filers Group filing | Other | 1,219 | $140.60 | $171k |
| 2026-05-08 | 4 co-filers Group filing | Option exercise | 1,219 | $0.00 | — |
| 2026-05-07 | Byers Deborah L Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Murray Mark A Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Thomas David A Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Williams Valerie Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Skaggs Robert C Jr Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Brandon David Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Akins Nicholas K Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Santos Cassandra Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Torgow Gary Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | Mcclure Charles G Director | Grant | 1,230 | $0.00 | — |
| 2026-05-07 | 4 co-filers Group filing | Grant | 1,230 | $0.00 | — |
| 2026-05-04 | 3 co-filers Group filing | Option exercise | 1,425 | $0.00 | $0 |
| 2026-05-04 | 3 co-filers Group filing | Option exercise | 1,425 | $0.00 | $0 |
| 2026-05-04 | 3 co-filers Group filing | Option exercise | 1,425 | $0.00 | $0 |
| 2026-05-04 | 3 co-filers Group filing | Option exercise | 1,425 | $0.00 | $0 |
| 2026-05-04 | 3 co-filers Group filing | Other | 1 | $146.73 | $122 |
| 2026-05-04 | 3 co-filers Group filing | Other | 1,425 | $146.73 | $209k |
| 2026-05-04 | 3 co-filers Group filing | Other | 1,425 | $146.73 | $209k |
| 2026-05-04 | 3 co-filers Group filing | Other | 1,425 | $146.73 | $209k |
| 2026-05-04 | 3 co-filers Group filing | Option exercise | 1,425 | $0.00 | — |
| 2026-05-04 | 3 co-filers Group filing | Option exercise | 1,425 | $0.00 | — |
| 2026-05-04 | 3 co-filers Group filing | Option exercise | 1,425 | $0.00 | — |
| 2026-05-04 | 3 co-filers Group filing | Option exercise | 1,425 | $0.00 | — |
| 2026-04-01 | Torgow Gary Director | Grant | 246 | $147.12 | — |
| 2026-04-01 | Brandon David Director | Grant | 246 | $147.12 | — |
| 2026-02-04 | 3 co-filers President & CEO | Grant | 18,508 | $0.00 | $0 |
| 2026-02-04 | 3 co-filers Vice Chairman & CFO | Grant | 14,388 | $0.00 | $0 |
| 2026-02-04 | 4 co-filers Pres. & COO-DTE Electric Co. | Grant | 3,200 | $0.00 | $0 |
| 2026-02-04 | 3 co-filers President & COO - DTE Gas | Grant | 5,850 | $0.00 | $0 |
| 2026-02-04 | 3 co-filers Executive Chairman | Grant | 51,028 | $0.00 | $0 |
| 2026-02-04 | 3 co-filers Chief Accounting Officer | Grant | 987 | $0.00 | $0 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.